tonight will reveal if more delays, page-7

Thanks Livas1,

I had another look at the undertakings given to takeover panel

ANZ has undertaken to:
• Sell down its interest in BioProspect to less than 5% of BPO’s issued capital
within 12 months.
• Not vote any BioProspect securities during the sell down, without the consent
of the Panel.
• If ANZ holds more than 5% of BioProspect’s issued capital after 12 months, to
hand over to ASIC for sale its remaining holding, to be disposed of as
determined by the Panel.
• Unless the Panel otherwise consents, conduct the sell down in the ordinary
course of trading on the ASX and not to sell BioProspect securities comprising
an amount greater than 5% of BioProspect’s issued capital over any three
consecutive trading days.


These undertakings apply to all the companies in which ANZ took shares after OPES collapse.


as ANZ has stopped selling SLA shares in bulk, this could mean

- There are no arranged buyers to buy shares in millions (money issues ??)

- They have applied to TO panel and as yet no decision has been received. TO panel takes about 2 to 3weeks to grant exemption. As the last big sale was on 30th June, the TO panel decision may not have been received as yet.

Either way we will know in about 2 weeks as they have to release a quarterly